Next week brings the start of July, and with it another holiday.

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Fortrea Holdings, Inc. (NASDAQ: FTRE) between July 3, 2023 and February 28, 2025, both dates inclusive (the “Class Period”), of the important August 1, 2025 lead plaintiff deadline.

NEW YORK, June 25, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Elevance Health, Inc. (NYSE: ELV) between April 18, 2024 and October 16, 2024, both dates inclusive (the “Class Period”), of the important July 11, 2025 lead plaintiff deadline.

The market is overestimating the negative impact of policy crackdowns, DoJ investigations, and Medicare/Medicaid cuts on UnitedHealth Group's long-term fundamentals. While legislative and regulatory headwinds will likely compress margins and slow growth, UNH's diversified business model and strong market position provide resilience and upside potential. Optum Insights is a key growth catalyst, with double-digit margin expansion and AI-driven healthcare analytics offsetting weakness in other segments.

Paul Sankey, Sankey Research, joins 'Power Lunch' to discuss Sankey's take on reports of Shell's potential acquisition of BP.

As AT&T transitions its broadband service from copper to fiber, the company anticipates $6 billion in cost savings when its copper network is taken off-line. CFO Pascal Desroches says the company is also getting financial returns from selling the copper it's no longer using.

H.C. Wainwright analyst Heiko F. Ihle reiterated a Buy rating on U.S. Gold Corp. USAU with a price forecast of $15.

RADNOR, Pa., June 25, 2025 (GLOBE NEWSWIRE) -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States District Court for the Eastern District of Virginia against Reddit, Inc. (“Reddit”) (NYSE: RDDT) on behalf of those who purchased or otherwise acquired Reddit securities between October 29, 2024, and May 20, 2025, inclusive (the “Class Period”). The lead plaintiff deadline is August 18, 2025.

Shares of Ohio-based KeyCorp have been pretty flat since I opened on the bank last October, broadly tracking the fortunes of the wider regional bank space. The bank's margin-driven recovery continues, which should result in strong earnings growth over the next few years. The stock now trades for less than 10x consensus 2026 EPS, offering today's buyer attractive total return potential.

Nvidia shares were on track to close at an all-time high on Wednesday as Wall Street investors shook off fears that US limits on exports to China would hurt the company's business.

LOS ANGELES--(BUSINESS WIRE)--Surf Air Mobility Inc. (NYSE: SRFM) (the “Company”), a leading regional air mobility platform, announced today that it has entered into definitive agreements for the purchase and sale of 10,800,002 shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $2.50 per share (or pre-funded warrant in lieu thereof) in a registered direct offering. The offering is expected to close on or about June 26, 2025, subject to the satisfaction of cus.

Santander Bank has made a deal to sell seven branches in Pennsylvania as it continues its transformation into a national, digital-first bank. [contact-form-7] The firm agreed to sell the branches to Syracuse, New York-based Community Bank, which operates about 200 branches in Pennsylvania, New York, Vermont and Massachusetts.

Winnebago Industries, Inc. (NYSE:WGO ) Q3 2025 Earnings Conference Call June 25, 2025 10:00 AM ET Company Participants Bryan L. Hughes - CFO and Senior VP of Finance, Investor Relations & Business Development Michael J.

This is why the stock is on pace to reach a new all-time closing high and reclaim its spot as the largest company by market capitalization.

Paychex, Inc. (NASDAQ:PAYX ) Q4 2025 Results Conference Call June 25, 2025 9:30 AM ET Company Participants John B. Gibson - President, CEO & Director Robert Lewis Schrader - Chief Financial Officer Conference Call Participants Andrew Owen Nicholas - William Blair & Company L.L.C.

DLocal (DLO) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might help the stock continue moving higher in the near term.

Despite a revenue miss, Pfizer's Q1 earnings crushed estimates due to aggressive, structural cost-cutting, signaling a powerful shift towards operational and margin excellence. Management is expanding its cost-savings program to a massive $7.7 billion by 2027, aiming to create a powerful EPS growth story despite flat revenues. Pfizer's non-COVID portfolio is firing on all cylinders, with key drugs like Nurtec and Padcev showing robust double-digit growth, proving underlying business health.

I use YCharts' Value Score and Ben Graham Formula Value All Stars, or GASV, to identify large-cap stocks offering strong value and dividend safety. Seventeen out of twenty-four "safer" lowest-priced Dividend Dogs of the GASV are currently fair-priced and ready to buy for income investors. Top ten GASV stocks offer projected average net gains of 32.99% by June 2026, with yields ranging from 8.94% to 13.81%.

NEW YORK , June 25, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) securities between May 9, 2024 and May 8, 2025, both dates inclusive (the "Class Period"), of the important July 14, 2025 lead plaintiff deadline. So What: If you purchased Iovance securities during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

SAN FRANCISCO , June 25, 2025 /PRNewswire/ -- On June 23, 2025 investors in Hims & Hers Health, Inc. (NYSE: HIMS) saw the price of their shares crash over 30% after Novo Nordisk announced that it terminated its collaboration with the telehealth company due to concerns about Hims & Hers' sales and "deceptive" marketing of the weight loss drug Wegovy®. This news has prompted national shareholders rights firm Hagens Berman to open an investigation into possible violations of the securities laws.